Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
Recruiting · NCT07084727 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Antwerp
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
Who can take part
Inclusion criteria
- at least 18 years old
- willing to undergo vascular assessments
- informed consent signed
Exclusion criteria
- Unwilling to provide informed consent
- Open-angle glaucoma
- Epilepsia
- (gestational) Diabetes
- Multiple pregnancies
- Fetal malformations
- Hypercholesterolemia
- Kidney disease
- Auto-immune disorders
- Connective tissue diseases
Where it is running
1 location listed.
- Antwerp University Hospital - Edegem, Antwerp, Belgium